St. Jude Starts Pivotal Depression Trial For Deep Brain Stimulator
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical officially entered the race Feb. 7 to successfully market an implantable neurostimulator for depression, announcing FDA clearance for a pivotal trial testing its Libra deep brain stimulation device for the indication
You may also be interested in...
St. Jude/ANS Spotlights Trials Of Three Neurostim Indications
St. Jude Medical is touting neuromodulation as the next big new market opportunity for the company
St. Jude/ANS Spotlights Trials Of Three Neurostim Indications
St. Jude Medical is touting neuromodulation as the next big new market opportunity for the company
Northstar Neuroscience Says It Has The Cash To Overcome EVEREST Setback
Northstar Neuroscience says it has enough cash reserves to continue developing its cortical stimulation technology for tinnitus and depression, despite the disappointing results of the first pivotal trial for a stroke indication
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: